|
FEM1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.39730507351533E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78620007673658E-10 |
| Normal-vs-Stage2 |
1.01299999499815E-08 |
| Normal-vs-Stage3 |
1.833230E-04 |
| Normal-vs-Stage4 |
7.664400E-03 |
| Stage1-vs-Stage2 |
6.928600E-01 |
| Stage1-vs-Stage3 |
1.633610E-01 |
| Stage1-vs-Stage4 |
8.626000E-01 |
| Stage2-vs-Stage3 |
1.554590E-01 |
| Stage2-vs-Stage4 |
9.817000E-01 |
| Stage3-vs-Stage4 |
4.004800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04749550647421E-11 |
| Normal-vs-AfricanAmerican |
3.51259999975539E-07 |
| Normal-vs-Asian |
1.592340E-04 |
| Caucasian-vs-AfricanAmerican |
1.960050E-01 |
| Caucasian-vs-Asian |
7.275800E-01 |
| AfricanAmerican-vs-Asian |
4.222400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3871016274768E-11 |
| Normal-vs-Female |
6.86740000421793E-08 |
| Male-vs-Female |
1.086590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.38669999927288E-08 |
| Normal-vs-Extreme_Weight |
5.44119971301882E-10 |
| Normal-vs-Obese |
4.0029999981428E-08 |
| Normal-vs-Extreme_Obese |
2.879400E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.378400E-01 |
| Normal_Weight-vs-Obese |
4.001800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.129400E-01 |
| Extreme_Weight-vs-Obese |
2.141200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.189800E-01 |
| Obese-vs-Extreme_Obese |
5.861200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.761300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.91670002092081E-09 |
| Normal-vs-Age(61-80Yrs) |
7.26829707531351E-12 |
| Normal-vs-Age(81-100Yrs) |
4.12330000143513E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.274200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.072200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.264400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.082000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.037370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.239200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.69140043585026E-10 |
| Normal-VS-Type2 PRCC |
6.60779986283444E-10 |
| Normal-VS-KIRP CIMP |
5.91249999999377E-05 |
| Normal-VS-Unclassified PRCC |
1.61411999999306E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.178800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.766000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.417600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.994400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.315800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.399200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31159535957204E-11 |
| Normal-vs-N1 |
8.441900E-04 |
| Normal-vs-N2 |
6.32629999999246E-05 |
| N0-vs-N1 |
1.773010E-01 |
| N0-vs-N2 |
2.663600E-01 |
| N1-vs-N2 |
1.838230E-01 |
|
|
